Search

Search Constraints

You searched for: Author/Creator Zuo, Dongqing

Search Results

2. Alternol, a natural compound, exerts an anti‐tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways. Issue 2 (14th September 2016)

3. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma. Issue 4 (15th February 2019)

4. Antitumor activity of Raddeanin A is mediated by Jun amino‐terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma. Issue 5 (13th April 2019)

5. Correlation between Patient‐Derived Xenograft Modeling and Prognosis in Osteosarcoma. Issue 6 (10th May 2022)

7. Hiporfin‐Mediated Photodynamic Therapy in Preclinical Treatment of Osteosarcoma. (16th February 2015)

8. Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic Degradation. Issue 8 (10th February 2019)

9. Osteosarcoma Therapy: Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic Degradation (Adv. Sci. 8/2019). Issue 8 (17th April 2019)